特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

組織診断の世界市場:産業動向、シェア、規模、成長率、機会、予測

Tissue Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024

発行 IMARC Services Private Limited 商品コード 864972
出版日 ページ情報 英文 106 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=106.59円で換算しております。
組織診断の世界市場:産業動向、シェア、規模、成長率、機会、予測 Tissue Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024
出版日: 2019年06月10日 ページ情報: 英文 106 Pages
概要

当レポートでは、世界の組織診断市場について調査分析し、市場実績、セグメント別の市場分析、価格動向、バリューチェーン分析、主要促進要因、市場構造、主要企業などについて、体系的な情報を提供しています。

第1章 序文

第2章 調査範囲・手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界の組織診断市場

  • 市場概要
  • 市場実績
  • 市場内訳:製品タイプ別
  • 市場内訳:技術別
  • 市場内訳:疾患別
  • 市場内訳:エンドユーザー別
  • 市場内訳:地域別
  • 市場予測

第6章 市場内訳:製品タイプ別

  • 機器
  • 消耗品

第7章 市場内訳:技術別

  • IHC (免疫組織化学)
  • ISH (in situ ハイブリダイゼーション)
  • デジタルパソロジー・ワークフロー管理
  • 特殊染色法

第8章 市場内訳:疾患別

  • 乳がん
  • 胃がん
  • リンパ腫
  • 前立腺がん
  • 非小細胞肺がん (NSCLC)
  • その他

第9章 市場内訳:エンドユーザー別

  • 病院
  • 研究機関
  • 製薬会社
  • CRO
  • その他

第10章 市場内訳:地域別

  • 北米
  • 欧州
  • アジア太平洋地域
  • 中東・アフリカ
  • ラテンアメリカ

第11章 SWOT分析

第12章 バリューチェーン分析

第13章 ファイブフォース分析

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Roche
    • Danaher
    • Thermo Fisher Scientific
    • Abbott
    • Agilent Technologies
    • Merck
    • サクラファインテックジャパン
    • Abcam
    • BD
    • Qiagen
    • Bio SB
    • Biogenex
    • Cell Signaling Technology
図表

List of Figures

  • Figure 1: Global: Tissue Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Tissue Diagnostics Market: Sales Value (in Billion US$), 2013-2018
  • Figure 3: Global: Tissue Diagnostics Market: Breakup by Product Type (in %), 2018
  • Figure 4: Global: Tissue Diagnostics Market: Breakup by Technology (in %), 2018
  • Figure 5: Global: Tissue Diagnostics Market: Breakup by Disease (in %), 2018
  • Figure 6: Global: Tissue Diagnostics Market: Breakup by End-User (in %), 2018
  • Figure 7: Global: Tissue Diagnostics Market: Breakup by Region (in %), 2018
  • Figure 8: Global: Tissue Diagnostics Industry: SWOT Analysis
  • Figure 9: Global: Tissue Diagnostics Industry: Value Chain Analysis
  • Figure 10: Global: Tissue Diagnostics Industry: Porter's Five Forces Analysis
  • Figure 11: Global: Tissue Diagnostics Market Forecast: Sales Value (in Billion US$), 2019-2024
  • Figure 12: Global: Tissue Diagnostics (Instruments) Market: Sales Value (in Million US$), 2013-2018
  • Figure 13: Global: Tissue Diagnostics (Instruments) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 14: Global: Tissue Diagnostics (Consumables) Market: Sales Value (in Million US$), 2013-2018
  • Figure 15: Global: Tissue Diagnostics (Consumables) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 16: Global: Tissue Diagnostics (Immunohistochemistry) Market: Sales Value (in Million US$), 2013-2018
  • Figure 17: Global: Tissue Diagnostics (Immunohistochemistry) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 18: Global: Tissue Diagnostics (In Situ Hybridization) Market: Sales Value (in Million US$), 2013-2018
  • Figure 19: Global: Tissue Diagnostics (In Situ Hybridization) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 20: Global: Tissue Diagnostics (Digital Pathology and Workflow Management) Market: Sales Value (in Million US$), 2013-2018
  • Figure 21: Global: Tissue Diagnostics (Digital Pathology and Workflow Management) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 22: Global: Tissue Diagnostics (Special Staining) Market: Sales Value (in Million US$), 2013-2018
  • Figure 23: Global: Tissue Diagnostics (Special Staining) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 24: Global: Tissue Diagnostics (Breast Cancer) Market: Sales Value (in Million US$), 2013-2018
  • Figure 25: Global: Tissue Diagnostics (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 26: Global: Tissue Diagnostics (Gastric Cancer) Market: Sales Value (in Million US$), 2013-2018
  • Figure 27: Global: Tissue Diagnostics (Gastric Cancer) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 28: Global: Tissue Diagnostics (Lymphoma) Market: Sales Value (in Million US$), 2013-2018
  • Figure 29: Global: Tissue Diagnostics (Lymphoma) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 30: Global: Tissue Diagnostics (Prostate Cancer) Market: Sales Value (in Million US$), 2013-2018
  • Figure 31: Global: Tissue Diagnostics (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 32: Global: Tissue Diagnostics (Non-Small Cell Lung Cancer) Market: Sales Value (in Million US$), 2013-2018
  • Figure 33: Global: Tissue Diagnostics (Non-Small Cell Lung Cancer) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 34: Global: Tissue Diagnostics (Other Diseases) Market: Sales Value (in Million US$), 2013-2018
  • Figure 35: Global: Tissue Diagnostics (Other Diseases) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 36: Global: Tissue Diagnostics (Hospitals) Market: Sales Value (in Million US$), 2013-2018
  • Figure 37: Global: Tissue Diagnostics (Hospitals) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 38: Global: Tissue Diagnostics (Research Laboratories) Market: Sales Value (in Million US$), 2013-2018
  • Figure 39: Global: Tissue Diagnostics (Research Laboratories) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 40: Global: Tissue Diagnostics (Pharmaceutical Companies) Market: Sales Value (in Million US$), 2013-2018
  • Figure 41: Global: Tissue Diagnostics (Pharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 42: Global: Tissue Diagnostics (Contract Research Organizations) Market: Sales Value (in Million US$), 2013-2018
  • Figure 43: Global: Tissue Diagnostics (Contract Research Organizations) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 44: Global: Tissue Diagnostics (Other End-Users) Market: Sales Value (in Million US$), 2013-2018
  • Figure 45: Global: Tissue Diagnostics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 46: North America: Tissue Diagnostics Market: Sales Value (in Million US$), 2013-2018
  • Figure 47: North America: Tissue Diagnostics Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 48: Europe: Tissue Diagnostics Market: Sales Value (in Million US$), 2013-2018
  • Figure 49: Europe: Tissue Diagnostics Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 50: Asia Pacific: Tissue Diagnostics Market: Sales Value (in Million US$), 2013-2018
  • Figure 51: Asia Pacific: Tissue Diagnostics Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 52: Middle East and Africa: Tissue Diagnostics Market: Sales Value (in Million US$), 2013-2018
  • Figure 53: Middle East and Africa: Tissue Diagnostics Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 54: Latin America: Tissue Diagnostics Market: Sales Value (in Million US$), 2013-2018
  • Figure 55: Latin America: Tissue Diagnostics Market Forecast: Sales Value (in Million US$), 2019-2024

List of Tables

  • Table 1: Global: Tissue Diagnostics Market: Key Industry Highlights, 2018 and 2024
  • Table 2: Global: Tissue Diagnostics Market Forecast: Breakup by Product Type (in Million US$), 2019-2024
  • Table 3: Global: Tissue Diagnostics Market Forecast: Breakup by Technology (in Million US$), 2019-2024
  • Table 4: Global: Tissue Diagnostics Market Forecast: Breakup by Disease (in Million US$), 2019-2024
  • Table 5: Global: Tissue Diagnostics Market Forecast: Breakup by End-User (in Million US$), 2019-2024
  • Table 6: Global: Tissue Diagnostics Market Forecast: Breakup by Region (in Million US$), 2019-2024
  • Table 7: Global: Tissue Diagnostics Market Structure
  • Table 8: Global: Tissue Diagnostics Market: Key Players
目次
Product Code: SR1019A34_Report

The global tissue diagnostics market reached a value of US$ 3.8 Billion in 2018. Tissue diagnostics include the analysis and testing of specific tissue samples by capturing the biological context of diseases. They are used to detect certain medical conditions like cancer and inflammatory disorders and reveal the exact type and degree of malignancy which assists in identifying potential causes and treatment options. Tissue diagnostics are highly accurate, inexpensive and can be carried out by different techniques like core and open biopsy. Nowadays, advanced technologies like immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology and special staining are also being employed for performing these diagnoses.

Owing to the declining fertility rates and increased life expectancy, the overall share of the geriatric population is currently experiencing steady growth worldwide. This is a crucial factor contributing to the market growth as older adults are more susceptible to chronic diseases and thus require frequent check-ups and diagnoses. Apart from this, altering food patterns, rising alcohol consumption and reduced physical activities among individuals have led to a rise in the incidences of several lifestyle diseases. In addition to this, the rising prevalence of various types of cancers among all age groups has also led to a surge in demand for these diagnostic services. Looking forward, IMARC Group expects the market to reach a value of US$ 5.5 Billion by 2024, registering a CAGR of 6.5% during 2019-2024.

Report Coverage:

  • Historical, Current and Future Market Trends

Market Breakup by Product Type:

  • Instruments
  • Consumables

Market Breakup by Technology:

  • Immunohistochemistry
  • In Situ Hybridization
  • Digital Pathology and Workflow Management
  • Special Staining

Market Breakup by Disease:

  • Breast Cancer
  • Gastric Cancer
  • Lymphoma
  • Prostate Cancer
  • Non-Small Cell Lung Cancer
  • Others

Market Breakup by End-User:

  • Hospitals
  • Research Laboratories
  • Pharmaceutical Companies
  • Contract Research Organizations
  • Others

Market Breakup by Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Competitive Landscape:

  • The report has also analysed the competitive landscape of the market with some of the key players being Roche, Danaher, Thermo Fisher Scientific, Abbott, Agilent Technologies, Merck, Sakura Finetek Japan, Abcam, BD, Qiagen, Bio SB, Biogenex, Cell Signaling Technology, etc

Key Questions Answered in This Report:

  • How has the global tissue diagnostics market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global tissue diagnostics industry?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the disease?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the global tissue diagnostics industry?
  • What are the key driving factors and challenges in the global tissue diagnostics industry?
  • What is the structure of the global tissue diagnostics industry and who are the key players?
  • What is the degree of competition in the global tissue diagnostics industry?
  • What are the profit margins in the global tissue diagnostics industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Tissue Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Market Breakup by Product Type
  • 5.4 Market Breakup by Technology
  • 5.5 Market Breakup by Disease
  • 5.6 Market Breakup by End-User
  • 5.7 Market Breakup by Region
  • 5.8 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Immunohistochemistry
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 In Situ Hybridization
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Digital Pathology and Workflow Management
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Special Staining
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Disease

  • 8.1 Breast Cancer
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Gastric Cancer
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Lymphoma
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Prostate Cancer
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Non-Small Cell Lung Cancer
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Research Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Pharmaceutical Companies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Contract Research Organizations
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Europe
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Asia Pacific
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Middle East and Africa
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Latin America
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

  • 14.1 Price Indicators
  • 14.2 Price Structure
  • 14.3 Margin Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Roche
    • 15.3.2 Danaher
    • 15.3.3 Thermo Fisher Scientific
    • 15.3.4 Abbott
    • 15.3.5 Agilent Technologies
    • 15.3.6 Merck
    • 15.3.7 Sakura Finetek Japan
    • 15.3.8 Abcam
    • 15.3.9 BD
    • 15.3.10 Qiagen
    • 15.3.11 Bio SB
    • 15.3.12 Biogenex
    • 15.3.13 Cell Signaling Technology